December 15, 2017 /

Understanding Gene Therapy, Part 3 – Galgt2 and Dup2 (December 2017)

Understanding Gene Therapy, Part 3 – Galgt2 and Dup2 (December 2017)

As part of our ongoing series on Understanding Gene Therapy, PPMD hosted a webinar with Dr. Kevin Flanigan, Director of the Center for Gene Therapy at Nationwide Children’s Hospital. Dr. Flanigan helped explain two gene therapy technologies that he and his team at Nationwide are exploring: GALGT2 and Dup2. This webinar is the third in our series on Gene Therapy where we are bring leaders in gene therapy technology to you to discuss their latest projects and provide an update on this incredibly exciting and expanding field.

Posted on December 15, 2017

Join Our Mailing List